Abcellera Biologics Inc (ABCL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
Sales | 12,192 | 21,543 | 101,383 | 45,917 | 316,581 |
Gross Profit | 12,192 | 21,543 | 101,383 | 45,917 | 316,581 |
Operating Expenses | 77,066 | 59,321 | 63,648 | 54,313 | 91,631 |
Operating Income | -64,874 | -37,778 | 37,735 | -8,396 | 224,950 |
Other Income | 16,726 | 6,367 | 8,852 | 1,510 | 5,859 |
Pre-tax Income | -48,148 | -31,411 | 46,587 | -6,886 | 230,809 |
Income Tax | -8,038 | -1,518 | 19,963 | -101 | 62,236 |
Net Income Continuous | -40,110 | -29,893 | 26,624 | -6,785 | 168,573 |
Net Income | $-40,110 | $-29,893 | $26,624 | $-6,785 | $168,573 |
EPS Basic Total Ops | -0.14 | -0.10 | 0.09 | -0.02 | 0.59 |
EPS Basic Continuous Ops | -0.14 | -0.11 | 0.09 | -0.02 | 0.59 |
EPS Diluted Total Ops | -0.14 | -0.10 | 0.08 | -0.02 | 0.54 |
EPS Diluted Continuous Ops | -0.14 | -0.10 | 0.08 | -0.02 | 0.54 |
EPS Diluted Before Non-Recurring Items | -0.14 | -0.10 | 0.08 | N/A | N/A |
EBITDA(a) | $-57,754 | $-22,418 | $44,463 | $-2,355 | $229,923 |